12:04 PM EDT, 08/06/2025 (MT Newswires) -- (Updates with recent stock price movement in the headline and first paragraph.)

Lantheus ( LNTH ) shares were down more than 28% in recent Wednesday trading after the company reported Q2 adjusted earnings and revenue that missed analyst expectations and cut its 2025 outlook

The company reported Q2 adjusted earnings Wednesday of $1.57 per diluted share, down from $1.80 a year earlier.

Analysts surveyed by FactSet expected $1.68.

Worldwide revenue for the quarter ended June 30 was $378 million, down from $394.1 million a year earlier.

Analysts surveyed by FactSet expected $387.9 million.

The radiopharmaceutical company lowered its 2025 adjusted EPS guidance to between $5.50 and $5.70 from the prior outlook range of between $6.60 and $6.70. Analysts surveyed by FactSet expect $6.64.

Lantheus ( LNTH ) also lowered its 2025 revenue outlook to a range of $1.48 billion to $1.51 billion from the previous guidance of $1.55 billion to $1.59 billion. Analysts surveyed by FactSet expect $1.57 billion.

Price: 51.69, Change: -20.94, Percent Change: -28.83